1. Upshur CC, Luckmann RS, Savageau JA. Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Int Med. 2006;21:652–5.
2. Meier B. Opioid prescribing gets another look as FDA revisits mandatory doctor training. New York Times, 2 May, 2016, p. B1. Available from: http://www.nytimes.com/2016/05/03/business/fda-again-reviews-mandatory-training-for-painkiller-prescribers.html?_r=0 . Accessed 14 May 2016.
3. US Food and Drug Administration. Califf, FDA top officials call for sweeping review of agency opioid policies. FDA News Release, 4 Feb, 2016. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm484765.htm . Accessed 14 May 2016.
4. Pollack A, Creswell J. Martin Shrekli, the mercurial man behind the drug price that went viral. New York Times, 22 Sep, 2015. Available from: http://www.nytimes.com/2015/09/23/business/big-price-increase-for-an-old-drug-will-be-rolled-back-turing-chief-says.html?_r=0 . Accessed 15 May 2016.
5. Robbins R. How a price hike for a drug for infants with epilepsy drove an uproar. STAT, 17 Nov, 2015. Available from: https://www.statnews.com/2015/11/17/infants-epilepsy-drug-price/ . Accessed 14 May 2016.